Novel Novartis malaria compound shows potential to be effective against infections resistant to all currently available antimalarial drugs
- Details
- Category: Novartis

Bristol-Myers Squibb awards first "Golden Tickets" for LabCentral to PanTher, Suono Bio
- Details
- Category: Bristol-Myers Squibb

Abbott to sell Abbott Medical Optics to Johnson & Johnson for $4.325 billion
- Details
- Category: Abbott

Novartis Foundation showcases progress in leprosy elimination programs at 19th International Leprosy Congress
- Details
- Category: Novartis

Pfizer launches new "Moodivator" app to help support, encourage and motivate people with depression
- Details
- Category: Pfizer

PEPFAR and AstraZeneca launch partnership across HIV and hypertension services in Africa
- Details
- Category: AstraZeneca

Sanofi and Verily Life Sciences announce launch of Onduo, a joint venture to develop comprehensive diabetes management platform
- Details
- Category: Sanofi

More Pharma News ...
- Roche ranked most sustainable healthcare company in the Dow Jones Sustainability Index for the eighth year running
- Pfizer appoints chief scientific officer for neuroscience research
- Bristol-Myers Squibb employees cycle Coast to Coast to raise money and awareness for cancer research
- GSK announce positive results from the COPD Salford Lung Study
- Benralizumab phase III trials show positive results in severe asthma
- Amgen obtains global development and commercial rights from Boehringer Ingelheim for investigational BiTE® immuno-oncology drug for multiple myeloma
- Saniona and Boehringer Ingelheim sign collaboration agreement in schizophrenia